Lotfollahi, Mohammad http://orcid.org/0000-0001-6858-7985
Naghipourfar, Mohsen http://orcid.org/0000-0003-0465-0126
Luecken, Malte D. http://orcid.org/0000-0001-7464-7921
Khajavi, Matin
Büttner, Maren http://orcid.org/0000-0002-6189-3792
Wagenstetter, Marco
Avsec, Žiga http://orcid.org/0000-0002-7790-8936
Gayoso, Adam http://orcid.org/0000-0001-9537-0845
Yosef, Nir http://orcid.org/0000-0001-9004-1225
Interlandi, Marta
Rybakov, Sergei
Misharin, Alexander V. http://orcid.org/0000-0003-2879-3789
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (ZT-I-0007)
Article History
Received: 30 July 2020
Accepted: 28 June 2021
First Online: 30 August 2021
Change Date: 15 November 2021
Change Type: Update
Change Details: In the version of this article initially published online, the following metadata was omitted and has now been included: Open access funding provided by Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (4209)
Competing interests
: F.J.T. reports ownership interest in Cellarity. N.Y. is an advisor and/or has equity in Celsius Therapeutics and Rheos Medicines. The remaining authors declare no competing interests.